Bioequivalence and Bioavailability Forum 19:57 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Biostats
Junior

India,
2018-03-29 12:39

Posting: # 18613
Views: 2,432
 

 bioequivalence criteria for NTID [Regulatives / Guidelines]

Dear All,

As per Draft Guidance on Warfarin Sodium bioequivalence criteria for NTID as
  1. Every study should pass the scaled average bioequivalence limits and
  2. Also regular unscaled bioequivalence limits of 80.00-125.00%.
  3. the upper limit of the 90% equal-tails confidence interval for σwT/σwR is less than or equal to 2.5
My understanding for 1 and 2 criteria as below,
  1. The 95% upper confidence bound for (YTYR)2θs2wR must be ≤ 0 and the point estimate of the Test/Reference geometric mean ratio must fall within 80.00 – 125.00%. (scaled average bioequivalence limits)
  2. 90% confidence interval should lies within 80–125% (unscaled bioequivalence limits)
Is this correct? Please guide me to understand the bioequivalence criteria of NTI drugs.

Thanks in advanced.
Helmut
Hero
avatar
Homepage
Vienna, Austria,
2018-03-29 14:27

@ Biostats
Posting: # 18615
Views: 2,161
 

 bioequivalence criteria for NTID

Hi Biostats,

your understanding of 1 & 2 is correct. Don’t forget #3!

» Please guide me to understand the bioequivalence criteria of NTI drugs.

Can you be more specific?

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
Biostats
Junior

India,
2018-03-30 06:25

@ Helmut
Posting: # 18623
Views: 2,069
 

 bioequivalence criteria for NTID

Thanks Sir,

Is it mandatory to check - point estimate of the Test/Reference geometric mean ratio must fall within 80.00 - 125.00%?


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]
Helmut
Hero
avatar
Homepage
Vienna, Austria,
2018-03-30 11:19

@ Biostats
Posting: # 18624
Views: 2,064
 

 GMR not relevant in ABE

Hi Biostats

» Is it mandatory to check - point estimate of the Test/Reference geometric mean ratio must fall within 80.00 - 125.00%?

See your condition #2 and the guidance

Every study should pass the scaled average bioequivalence limits and also regular unscaled bioequivalence limits of 80.00–125.00%.


What do you think where the GMR lies if a study passes ABE? It is only nice to know (unless you are concerned about this discussion). If a study fails ABE, the location of the GMR is even less relevant. Hence, the FDA does not ask for it.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
jag009
Hero

NJ,
2018-03-29 17:20

@ Biostats
Posting: # 18618
Views: 2,105
 

 bioequivalence criteria for NTID

» Please guide me to understand the bioequivalence criteria of NTI drugs.

This might help. A nice article from my professor...

Endrenyi - NTI

John
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,783 posts in 4,003 threads, 1,259 registered users;
online 10 (0 registered, 10 guests [including 9 identified bots]).

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed